AAAAAA
Results: 1-25/46
Authors:
VONMINCKWITZ G
KUHN W
THOMSSEN G
UNTCH M
BAUKNECHT T
EIDTMANN D
MOBUS V
DUBOIS A
LUCK HJ
Citation: G. Vonminckwitz et al., PHASE-III TRIAL COMPARING EPIRUBICIN PACLITAXEL VS EPIRUBICIN/CYCLOPHOSPHAMID AS FIRST LINE TREATMENT IN METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS OF A GERMAN AGO TRIAL/, European journal of cancer, 34, 1998, pp. 406-406
Authors:
MROSS K
HAUNS B
HARING B
BAUKNECHT T
MEERPOHL HG
UNGER C
MAIERLENZ H
Citation: K. Mross et al., CLINICAL-PHASE-I STUDY WITH ONE-HOUR PACLITAXEL INFUSION, Annals of oncology, 9(5), 1998, pp. 569-572
Authors:
BAUKNECHT T
Citation: T. Bauknecht, ROLE OF GEMCITABINE IN OVARIAN-CANCER, Annals of oncology, 9, 1998, pp. 11-11
Authors:
MOBUS V
SCHODER W
LUCK HJ
MEIER W
RICHTER B
WARM M
COSTA S
BAUKNECHT T
OLBRICHT S
NITZ U
JACKISCH C
DUBOIS A
Citation: V. Mobus et al., CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN OVARIAN-CANCER - AN AGO STUDY-GROUP PHASE-III TRIAL/, Annals of oncology, 9, 1998, pp. 661-661
Authors:
MEINHOLDHEERLEIN I
BRANDSTETTER T
KOMMOSS F
BETTENDORF H
HAGEDORN M
BAUKNECHT T
Citation: I. Meinholdheerlein et al., LOCALIZATION OF CYTOKERATIN-10 MESSENGER-RNA IN HUMAN EPIDERMIS USINGNONRADIOACTIVE IN-SITU HYBRIDIZATION AS A ROUTINE METHOD, Archives of dermatological research, 290(5), 1998, pp. 286-288
Authors:
BAUKNECHT T
SHI Y
Citation: T. Bauknecht et Y. Shi, OVEREXPRESSION OF C EBP-BETA REPRESSES HUMAN-PAPILLOMAVIRUS TYPE-18 UPSTREAM REGULATORY REGION ACTIVITY IN HELA-CELLS BY INTERFERING WITH THE BINDING OF TATA-BINDING PROTEIN/, Journal of virology, 72(3), 1998, pp. 2113-2124
Authors:
BRANDSTETTER T
NINCI E
FALKEN U
WAGNER E
HESS R
BAUKNECHT T
Citation: T. Brandstetter et al., RHG-CSF AFFECTS GENES INVOLVED IN MITOGEN SIGNALING AND EARLY GENE-EXPRESSION IN THE OVARIAN-CANCER CELL-LINE HEY, International journal of cancer, 75(6), 1998, pp. 847-854
Authors:
BRANDSTETTER T
NINCI E
KECK C
BAUKNECHT T
BRECKWOLDT M
Citation: T. Brandstetter et al., IMPORTANCE OF THE RECEPTOR AND SIGNAL-TRA NSDUCTION OF THE GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN CARCINOMA OF THE OVARY, Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 175-179
CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL - OPTIMIZING OF TREATMENT IN ADVANCED OVARIAN-CANCER/
Authors:
MOBUS V
JACKISCH C
LUCK HJ
MEIER W
BAUKNECHT T
COSTA S
RICHTER B
NITZ U
DUBOIS A
Citation: V. Mobus et al., CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL - OPTIMIZING OF TREATMENT IN ADVANCED OVARIAN-CANCER/, European journal of cancer, 33, 1997, pp. 531-531
Authors:
BAUKNECHT T
LUECK HJ
CALVERT H
KREIENBERG R
PASTOVIC R
Citation: T. Bauknecht et al., TOPOTECAN - A COMPASSIONATE USE STUDY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER REFRACTORY TO OTHER THERAPIES, European journal of cancer, 33, 1997, pp. 535-535
Authors:
BAUKNECHT T
Citation: T. Bauknecht, GENETIC AND CYTOGENETIC ALTERATIONS IN OVARIAN-CANCER, European journal of cancer, 33, 1997, pp. 618-618
Authors:
MROSS K
HARING B
HAUNS B
MAIERLENZ H
BAUKNECHT T
MEERPOHL HG
DIERGARTEN K
UNGER C
Citation: K. Mross et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY WITH TAXOL(R) GIVEN AS SHORT 1-HOUR INTRAVENOUS-INFUSION, European journal of cancer, 33, 1997, pp. 1135-1135
Authors:
DUBOIS A
LUCK HJ
BAUKNECHT T
MOBUS V
BOCHTLER H
DIERGARTEN K
MEERPOHL HG
Citation: A. Dubois et al., PHASE-I PHASE-II STUDY OF THE COMBINATION OF CARBOPLATIN AND PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER/, Annals of oncology, 8(4), 1997, pp. 355-361
Authors:
SCHWARZROEGER U
PETZOLDT B
WALDSCHMIDT R
WALKER RP
BAUKNECHT T
KIECHLE M
Citation: U. Schwarzroeger et al., UGP - A TUMOR-MARKER OF GYNECOLOGIC AND BREAST MALIGNANCIES - SPECIFICITY AND SENSITIVITY IN PRETHERAPEUTIC PATIENTS AND THE INFLUENCE OF HORMONAL SUBSTITUTION ON THE EXPRESSION OF UGP, Anticancer research, 17(4B), 1997, pp. 3041-3045
Authors:
MAIERLENZ H
HAUNS B
HAERING B
KOETTING J
MROSS K
UNGER C
BAUKNECHT T
DUBOIS A
MEERPOHL HG
HOLLAENDER N
DIERGARTEN K
Citation: H. Maierlenz et al., PHASE-I STUDY OF PACLITAXEL ADMINISTERED AS A 1-HOUR IN FUSION - TOXICITY AND PHARMACOKINETICS, Seminars in oncology, 24(6), 1997, pp. 16-19
Authors:
DUBOIS A
LUCK HJ
MEIER W
MOBUS V
COSTA S
RICHTER B
WARM M
BAUKNECHT T
SCHRODER W
OLBRICHT S
NITZ U
JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PACLITAXEL VERSUS CISPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - AN INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL OF THE ARBEITSGEMEINSCHAFT GYNAKOLOGISCHE-ONKOLOGIE OVARIAN-CANCER STUDY-GROUP/, Seminars in oncology, 24(5), 1997, pp. 44-52
Authors:
DUBOIS A
LUCK HJ
MEIER W
MOBUS V
COSTA S
RICHTER B
BAUKNECHT T
WARM M
SCHROEDER W
OLBRICHT S
NITZ U
JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(4), 1997, pp. 28-33
Authors:
MEERPOHL HG
DUBOIS A
LUCK HJ
KUHNLE H
MOBUS V
KREIENBERG R
BAUKNECHT T
KOCHLI O
BOCHTLER H
DIERGARTEN K
Citation: Hg. Meerpohl et al., PACLITAXEL COMBINED WITH CARBOPLATIN IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - A PHASE-I TRIAL, Seminars in oncology, 24(1), 1997, pp. 17-22
Authors:
BAUKNECHT T
Citation: T. Bauknecht, MECHANISMS OF CYTOSTATIC RESISTANCE IN OV ARIAN-CANCER, Geburtshilfe und Frauenheilkunde, 57(11), 1997, pp. 203-205
Authors:
BRANDSTETTER T
NINCI E
MAIER G
WAGNER E
BAUKNECHT T
Citation: T. Brandstetter et al., G-CSF-DEPENDENT EFFECTS ON CELL-CYCLE REGULATION AND P53 ACCUMULATIONIN OVARIAN-CANCER CELLS, Molecular biology of the cell, 7, 1996, pp. 1044-1044
Authors:
ARNOLD N
HAGELE L
WALZ L
SCHEMPP W
PFISTERER J
BAUKNECHT T
KIECHLE M
Citation: N. Arnold et al., OVERREPRESENTATION OF 3Q AND 8Q MATERIAL AND LOSS OF 18Q MATERIAL ARERECURRENT FINDINGS IN ADVANCED HUMAN OVARIAN-CANCER, Genes, chromosomes & cancer, 16(1), 1996, pp. 46-54
Authors:
PREUSS I
HAAS S
EICHHORN U
EBERHAGEN I
KAUFMANN M
BECK T
EIBL RH
DALL P
BAUKNECHT T
HENGSTLER J
WITTIG BM
DIPPOLD W
KAINA B
Citation: I. Preuss et al., ACTIVITY OF THE DNA-REPAIR PROTEIN O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN TUMOR AND CORRESPONDING NORMAL TISSUE, Cancer detection and prevention, 20(2), 1996, pp. 130-136
Authors:
BAUKNECHT T
SEE RH
SHI Y
Citation: T. Bauknecht et al., A NOVEL C EBP BETA-YY1 COMPLEX CONTROLS THE CELL-TYPE-SPECIFIC ACTIVITY OF THE HUMAN PAPILLOMAVIRUS TYPE-18 UPSTREAM REGULATORY REGION/, Journal of virology, 70(11), 1996, pp. 7695-7705
Authors:
DALL P
HEKELE A
IKENBERG H
GOPPINGER A
BAUKNECHT T
PFLEIDERER A
MOLL J
HOFMANN M
PONTA H
HERRLICH P
Citation: P. Dall et al., INCREASING INCIDENCE OF CD44V7 8 EPITOPE EXPRESSION DURING UTERINE CERVICAL CARCINOGENESIS/, International journal of cancer, 69(2), 1996, pp. 79-85
Authors:
SCHAFER CA
DUBOIS A
VACH W
PROMPELER H
BAUKNECHT T
BRECKWOLDT M
Citation: Ca. Schafer et al., ALTERATIONS OF SEROTONIN METABOLISM IN PR EECLAMPSIA, Geburtshilfe und Frauenheilkunde, 56(8), 1996, pp. 418-422